Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03439748 · ClinicalTrials.gov registry record · NA
Treatment for Affect Dimensions
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT03439748 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 85 participants.
The verdict
NCT03439748, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and targets of Positive Affect Treatment, a psychotherapy specifically aimed at enhancing reward sensitivity in individuals with low positive affect (a core feature of anhedonia) in the context of depression or anxiety. Target enrollment is 68 male and female participants with low positive affect and depression or anxiety and impaired functioning, between the ages of 18 and 65 years, who will be randomized to either Positive Affect Treatment or Negative Affect Treatment (designed to reduce threat sensitivity). Participants will complete laboratory tests, psychiatric assessments, and self-report questionnaires as part of the study. The total length of participation is around 4 months.
Interventions
- BEHAVIORAL Positive Affect Treatment
- BEHAVIORAL Negative Affect Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03439748
The ClinicalTrials.gov registry entry for NCT03439748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Positive Affect Treatment is the first listed.
NCT03439748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03439748 about?
NCT03439748 is a clinical study titled "Treatment for Affect Dimensions". The purpose of this study is to evaluate the efficacy and targets of Positive Affect Treatment, a psychotherapy specifically aimed at enhancing reward sensitivity in individuals with low positive affect (a core feature of anhedonia) in the context of depression or anxiety. Target enrollment is 68 m...
What is the current status of trial NCT03439748?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2019-02-01. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03439748?
The interventions under investigation include: Positive Affect Treatment (BEHAVIORAL), Negative Affect Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT03439748?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.